These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27753794)

  • 41. Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age.
    Greenberg DP; Vadheim CM; Wong VK; Marcy SM; Partridge S; Greene T; Chiu CY; Margolis HS; Ward JI
    Pediatr Infect Dis J; 1996 Jul; 15(7):590-6. PubMed ID: 8823852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with Engerix-B® in healthy Asian adults: A phase 3 randomized clinical trial.
    Diaz-Mitoma F; Popovic V; Spaans JN
    Vaccine; 2021 Jun; 39(29):3892-3899. PubMed ID: 34116873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An open-label, randomized efficacy and safety trial of subcutaneous and intramuscular BT088 (Fovepta) human hepatitis B immunoglobulin in neonates of HBV-carrier mothers.
    Buxmann H; Kamin W; Kriván G; Siklós P; Mendling W; Wartenberg-Demand A; Wolf DM; Schlösser RL
    J Perinat Med; 2012 Feb; 40(4):433-8. PubMed ID: 22752776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China.
    Wang ZZ; Li MQ; Wang P; Yang ZX; Wei L; Zeng Y; Li YP; Yan L; Liu XE; Zhuang H
    Vaccine; 2016 Feb; 34(8):1034-9. PubMed ID: 26801063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children.
    Raz R; Dagan R; Gallil A; Brill G; Kassis I; Koren R
    Vaccine; 1996 Feb; 14(3):207-11. PubMed ID: 8920701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease.
    Janssen RS; Mangoo-Karim R; Pergola PE; Girndt M; Namini H; Rahman S; Bennett SR; Heyward WL; Martin JT
    Vaccine; 2013 Nov; 31(46):5306-13. PubMed ID: 23727422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonates.
    Goldfarb J; Baley J; Medendorp SV; Seto D; Garcia H; Toy P; Watson B; Gooch MW; Krause D
    Pediatr Infect Dis J; 1994 Jan; 13(1):18-22. PubMed ID: 8170727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.
    Cooper CL; Davis HL; Angel JB; Morris ML; Elfer SM; Seguin I; Krieg AM; Cameron DW
    AIDS; 2005 Sep; 19(14):1473-9. PubMed ID: 16135900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B vaccine alone or in combination with anti-HBs immunoglobulin in the perinatal prophylaxis of babies born to HBsAg carrier mothers.
    Sehgal A; Gupta I; Sehgal R; Ganguly NK
    Acta Virol; 1992 Aug; 36(4):359-66. PubMed ID: 1362320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates.
    Minervini G; McCarson BJ; Reisinger KS; Martin JC; Stek JE; Atkins BM; Nadig KB; Liska V; Schödel FP; Bhuyan PK
    Vaccine; 2012 Feb; 30(8):1476-80. PubMed ID: 22227229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers.
    De Schryver A; Verstrepen K; Vandersmissen L; Vandermeeren N; Vernaillen I; Vranckx R; Van Damme P; van Sprundel M
    J Viral Hepat; 2011 Apr; 18(4):e5-10. PubMed ID: 20735800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lasting immune memory against hepatitis B in 12-13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.
    Behre U; Van Der Meeren O; Crasta P; Hanssens L; Mesaros N
    Hum Vaccin Immunother; 2016 Nov; 12(11):2916-2920. PubMed ID: 27653771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.